|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.510 USD | -5.65% |
|
-2.45% | - |
| Market Cap | 11.94M 10.35M 9.69M 8.84M 16.64M 1.14B 16.92M 114M 44.52M 570M 44.85M 43.87M 1.9B | P/E 2026 * |
22x | P/E 2027 * | 3.14x |
|---|---|---|---|---|---|
| Enterprise Value | 11.94M 10.35M 9.69M 8.84M 16.64M 1.14B 16.92M 114M 44.52M 570M 44.85M 43.87M 1.9B | EV / Sales 2026 * |
0.14x | EV / Sales 2027 * | 0.11x |
| Free-Float |
63.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -5.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Grigorios Siokas
CEO | Chief Executive Officer | 60 | 26/02/2016 |
Georgios Terzis
DFI | Director of Finance/CFO | 43 | 11/11/2020 |
| Chief Operating Officer | 56 | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 13/01/2014 | |
Grigorios Siokas
CHM | Chairman | 60 | 26/02/2016 |
John Hoidas
BRD | Director/Board Member | 59 | 18/11/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.65% | -2.45% | - | - | 11.94M | ||
| +2.49% | +8.59% | +34.04% | +104.92% | 105B | ||
| +1.30% | +2.87% | +52.39% | +160.08% | 55.88B | ||
| -0.34% | -0.67% | +3.86% | +267.70% | 24.12B | ||
| -0.18% | +0.36% | -12.43% | -13.43% | 8.28B | ||
| +0.61% | +4.63% | -29.94% | -24.40% | 7.75B | ||
| -0.48% | -2.95% | -12.07% | -21.55% | 6.69B | ||
| -0.80% | -0.82% | +16.80% | +16.07% | 6.16B | ||
| -0.49% | -3.78% | -4.68% | +19.96% | 5.01B | ||
| +0.40% | +0.20% | -5.59% | -4.42% | 3.75B | ||
| Average | -0.31% | +2.09% | +4.71% | +56.10% | 24.75B | |
| Weighted average by Cap. | +1.44% | +5.01% | +28.02% | +117.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 84.3M 73.05M 68.39M 62.4M 117M 8.04B 119M 802M 314M 4.02B 317M 310M 13.43B | 111M 96.02M 89.89M 82.02M 154M 10.57B 157M 1.05B 413M 5.29B 416M 407M 17.65B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COSM Stock
- COSM Stock
Select your edition
All financial news and data tailored to specific country editions
















